Science Explorer Back to mapMap
Discussion
Company · Milford · United States

Prothelia (United States)

Research works
3
▲ 25% vs 2018-21
Citations
107
38.6 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
68%
world 40%
International
60%
world 18%

Not ranked overall: Prothelia (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Prothelia (United States) work in?

In all years, 46% of research at Prothelia (United States) is in Health Sciences, 29% in Life Sciences. Its largest fields are Medicine (36%), Biochemistry, Genetics and Molecular Biology (29%), Environmental Science (14%).

Life Sciences29%Physical Sciences18%Health Sciences46%Social Sciences7%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 8 fields, with their numbers
    1. Medicine135.7%
    2. Dentistry07.1%
    3. Health Professions03.6%
    1. Biochemistry, Genetics and Molecular Biology128.6%
    1. Environmental Science014.3%
    2. Engineering03.6%
    1. Arts and Humanities03.6%
    2. Social Sciences03.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Prothelia (United States)?

The most cited paper from Prothelia (United States) is "Laminin-111 Protein Therapy Reduces Muscle Pathology and Improves Viability of a Mouse Model of Merosin-Deficient Congenital Muscular Dystrophy" (Jachinta E. Rooney, Jolie R. Knapp, Bradley L. Hodges et al., 2012), with 88 citations. Next come "Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy" (61) and "Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity" (52).

Most cited papers
#PaperReleasedCitations
1 Laminin-111 Protein Therapy Reduces Muscle Pathology and Improves Viability of a Mouse Model of Merosin-Deficient Congenital Muscular Dystrophy Jachinta E. Rooney, Jolie R. Knapp, Bradley L. Hodges et al. · American Journal Of Pathology Open access 6 Feb 2012 88
2 Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy Pam M. Van Ry, Priscilla Minogue, Bradley L. Hodges et al. · Human Molecular Genetics Open access 5 Sep 2013 61
3 Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity Takuya Osada, Xiao Yi Yang, Zachary C. Hartman et al. · Cancer Gene Therapy Open access 20 Feb 2009 52
4 Laminin-521 Protein Therapy for Glomerular Basement Membrane and Podocyte Abnormalities in a Model of Pierson Syndrome Meei‐Hua Lin, Joseph B Miller, Yamato Kikkawa et al. · Journal of the American Society of Nephrology Open access 22 Feb 2018 39
5 Estimating the Prevalence of LAMA2 Congenital Muscular Dystrophy using Population Genetic Databases Nicole J. Lake, Joel Phua, Wei Liu et al. · Journal of Neuromuscular Diseases 31 Mar 2023 19
All 5 most cited papers, with filters and sorting

Which research topics does Prothelia (United States) publish most on?

By volume in 2022-now: Cell Adhesion Molecules Research, Muscle Physiology and Disorders and Cellular Mechanics and Interactions.

  1. 1 Cell Adhesion Molecules Research Immunology and Allergy 0 works
  2. 2 Muscle Physiology and Disorders Molecular Biology 0 works
  3. 3 Cellular Mechanics and Interactions Cell Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available68.5%not open31.5%

World: 40% of research is openly available.

with international co-authors60.2%domestic only39.8%

World: 18% is written across borders.

How has Prothelia (United States)'s research output changed?

Output in 2022-2025 was 25% higher than in 2018-2021.

201020152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Milford

All research institutions in Milford

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Prothelia (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.